pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
650
stories
Jun 5, 26
STAT+: Will Makary’s FDA voucher program survive?
stat
Jun 5, 26
Tiny HHS office tasked with protecting research participants’ safety is running on fumes
stat
Jun 4, 26
Otsuka touts new IgAN evidence as it seeks full approval for Voyxact
endpoints
Jun 4, 26
STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
stat
Jun 4, 26
An ADC specialist sinks on safety concerns for blood cancer drug
biopharma dive
Jun 4, 26
STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
stat
Jun 4, 26
ADC Therapeutics' confirmatory data for Zynlonta muddied by death rates
endpoints
Jun 4, 26
STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?
stat
Jun 3, 26
FDA guides pharma on explaining unapproved drugs to payors
endpoints
Jun 3, 26
Mineralys makes money moves before looming hypertension approval
endpoints
Jun 3, 26
STAT+: What the pope’s encyclical on AI means for Catholic hospitals, and all of health care
stat
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
Jun 2, 26
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
biopharma dive
Jun 2, 26
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
stat
Jun 2, 26
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
stat
Jun 2, 26
AbiVax falls as safety worries cloud ‘landmark’ immune drug results
biopharma dive
Jun 1, 26
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
stat
Jun 1, 26
Shionogi wins US approval for first pill to prevent Covid following exposure
endpoints
Jun 1, 26
Servier buys into muscular dystrophy with potentially $2.7B deal
biopharma dive
Jun 1, 26
As FDA misses deadline on electric shock ban, disability advocates speak out
stat
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
Jun 1, 26
The hidden history of BPC-157, a favorite MAHA peptide
stat
May 30, 26
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
stat
May 29, 26
Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks
biopharma dive
May 29, 26
Replimune will again submit its melanoma drug for approval
endpoints
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 29, 26
STAT+: Allogene CEO David Chang stepping down
stat
May 29, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
May 28, 26
GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
biopharma dive
← prev
page 16 of 22
next →
